Literature DB >> 18826441

Unilateral versus bilateral middle cerebral artery detection of right-to-left shunt by power M-mode transcranial doppler.

Jill T Jesurum1, Cindy J Fuller, Mark A Moehring, Joshua Renz, Meryl Harley, Merrill P Spencer.   

Abstract

BACKGROUND AND
PURPOSE: Comparison was performed between unilateral and bilateral power M-mode transcranial Doppler to detect right-to-left circulatory shunt (RLS).
METHODS: Recorded Doppler data from 87 patients with confirmed RLS referred for transcatheter closure of patent foramen ovale were reanalyzed for embolic tracks (ET) counted from left and right temporal bone windows during bubble study. Unilateral counts were obtained by multiplying each side by 2; bilateral counts were obtained by summing left and right ET. Both unilateral and bilateral ET were converted to a 6-point logarithmic grade. Sex and age group subanalyses were performed.
RESULTS: At rest, significantly more ET were detected with bilateral versus unilateral detection (P= .01), but not following Valsalva (P= .13). Unilateral and bilateral detection were equally able to detect large RLS (grades IV or V) following Valsalva (P= 1.00). For the group aged > or =55 years, the right-hand side yielded greater ET than the left-hand side (mean difference 9%+/- 37; 95% confidence interval -3 to 21%) at rest (P= .01), but not following Valsalva (mean difference 1%+/- 25; 95% confidence interval -7 to 9%, P= .10).
CONCLUSIONS: Unilateral detection of ET by power M-mode transcranial Doppler is equivalent to bilateral detection to assess RLS.

Entities:  

Mesh:

Year:  2008        PMID: 18826441     DOI: 10.1111/j.1552-6569.2008.00280.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  1 in total

1.  PFO and right-to-left shunting in patients with obstructive sleep apnea.

Authors:  Marina Guchlerner; Peter Kardos; Eva Liss-Koch; Jennifer Franke; Nina Wunderlich; Stefan Bertog; Horst Sievert
Journal:  J Clin Sleep Med       Date:  2012-08-15       Impact factor: 4.062

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.